Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Luosujärvi R[au]:

[Systemic sclerosis]. Peltomaa R et al. Duodecim. (2013)

Synovial fluid detection in intra-articular injections using a bioimpedance probe (BIP) needle-a clinical study. Halonen S et al. Clin Rheumatol. (2017)

[Interruption of biological drugs in patients affected with inflammatory diseases]. Anttila VJ et al. Duodecim. (2016)

Search results

Items: 26

1.

Pain interference and associated factors in young adults with juvenile idiopathic arthritis.

Rebane K, Orenius T, Ristolainen L, Relas H, Kautiainen H, Luosujärvi R, Säilä H, Aalto K.

Scand J Rheumatol. 2019 Sep;48(5):408-414. doi: 10.1080/03009742.2019.1596308. Epub 2019 Jun 7.

PMID:
31170850
2.

Disability and health-related quality of life are associated with restricted social participation in young adults with juvenile idiopathic arthritis.

Rebane K, Ristolainen L, Relas H, Orenius T, Kautiainen H, Luosujärvi R, Aalto K, Säilä H.

Scand J Rheumatol. 2019 Mar;48(2):105-113. doi: 10.1080/03009742.2018.1493140. Epub 2018 Sep 30.

PMID:
30270708
3.

Outcome of transition phase patients with juvenile idiopathic arthritis.

Relas H, Luosujärvi R, Kosola S.

Mod Rheumatol. 2018 Sep;28(5):832-837. doi: 10.1080/14397595.2017.1416890. Epub 2018 Jan 8.

PMID:
29251024
4.

Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland.

Soini E, Asseburg C, Taiha M, Puolakka K, Purcaru O, Luosujärvi R.

Adv Ther. 2017 Oct;34(10):2316-2332. doi: 10.1007/s12325-017-0614-8. Epub 2017 Oct 3.

5.

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.

Väänänen T, Vuolteenaho K, Kautiainen H, Nieminen R, Möttönen T, Hannonen P, Korpela M, Kauppi MJ, Laiho K, Kaipiainen-Seppänen O, Luosujärvi R, Uusitalo T, Uutela T, Leirisalo-Repo M, Moilanen E; NEO-RACo Study Group.

PLoS One. 2017 Aug 25;12(8):e0183294. doi: 10.1371/journal.pone.0183294. eCollection 2017.

6.

[Interruption of biological drugs in patients affected with inflammatory diseases].

Anttila VJ, Haapamäki J, Peltomaa R, Tiippana-Kinnunen T, Luosujärvi R.

Duodecim. 2016;132(4):369-76. Review. Finnish.

PMID:
27017789
7.

Synovial fluid detection in intra-articular injections using a bioimpedance probe (BIP) needle-a clinical study.

Halonen S, Kankaanpää E, Kari J, Parmanne P, Relas H, Kronström K, Luosujärvi R, Peltomaa R.

Clin Rheumatol. 2017 Jun;36(6):1349-1355. doi: 10.1007/s10067-016-3210-4. Epub 2016 Feb 12.

PMID:
26873101
8.

[Systemic sclerosis].

Peltomaa R, Pettersson T, Tuompo R, Luosujärvi R.

Duodecim. 2013;129(19):1981-91. Review. Finnish.

PMID:
24218729
9.

[Imaging of inflammatory back pain].

Elo P, Laasonen L, Soini I, Luosujärvi R, Lohman M, Paimela L, Mikkonen R, Alasaarela E, Hannila I, Vidqvist KL, Kauppi M, Nordstöm D.

Duodecim. 2013;129(7):741-52. Review. Finnish.

PMID:
23720943
10.

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study).

Leirisalo-Repo M, Kautiainen H, Laasonen L, Korpela M, Kauppi MJ, Kaipiainen-Seppänen O, Luosujärvi R, Luukkainen R, Karjalainen A, Blåfield H, Uutela T, Ilva K, Julkunen HA, Paimela L, Puolakka K, Moilanen E, Hannonen PJ, Möttönen T; NEO-RACo Study Group.

Ann Rheum Dis. 2013 Jun;72(6):851-7. doi: 10.1136/annrheumdis-2012-201365. Epub 2012 Jun 30.

PMID:
22753402
11.

Cost-effectiveness modelling of sequential biologic strategies for the treatment of moderate to severe rheumatoid arthritis in Finland.

Puolakka K, Blåfield H, Kauppi M, Luosujärvi R, Peltomaa R, Leikola-Pelho T, Sennfalt K, Beresniak A.

Open Rheumatol J. 2012;6:38-43. doi: 10.2174/1874312901206010038. Epub 2012 Apr 26.

12.

The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.

Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T; FIN-RACo Trial Group.

Arthritis Rheum. 2009 May;60(5):1222-31. doi: 10.1002/art.24447.

13.

Prevalence of antibodies against Chlamydia trachomatis and incidence of C. trachomatis-induced reactive arthritis in an early arthritis series in Finland in 2000.

Savolainen E, Kettunen A, Närvänen A, Kautiainen H, Kärkkäinen U, Luosujärvi R, Kaipiainen-Seppänen O.

Scand J Rheumatol. 2009;38(5):353-6. doi: 10.1080/03009740902769559.

PMID:
19296404
14.

Serum soluble CD30 in early arthritis: a sign of inflammation but not a predictor of outcome.

Savolainen E, Matinlauri I, Kautiainen H, Luosujärvi R, Kaipiainen-Seppänen O.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5):922-5.

PMID:
19032830
15.

Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series.

Koivula MK, Savolainen E, Kaipiainen-Seppänen O, Kautiainen H, Luosujärvi R, Hakala M, Risteli J.

Rheumatology (Oxford). 2008 May;47(5):656-9. doi: 10.1093/rheumatology/ken092. Epub 2008 Mar 20.

PMID:
18356174
16.

Change of diagnoses and outcome of patients with early inflammatory joint diseases during a mean 13-month follow-up.

Savolainen E, Kautiainen H, Koivula MK, Luosujärvi R, Risteli J, Kaipiainen-Seppänen O.

Scand J Rheumatol. 2007 May-Jun;36(3):194-7.

PMID:
17657673
17.

Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience.

Konttinen L, Tuompo R, Uusitalo T, Luosujärvi R, Laiho K, Lähteenmäki J, Puurtinen-Vilkki M, Lanteri R, Kortelainen S, Karilainen H, Varjolahti-Lehtinen T, Nordström D; ROB-FIN Study Group.

Clin Rheumatol. 2007 Oct;26(10):1693-700. Epub 2007 Mar 1.

PMID:
17332979
18.

Assessing the intra- and inter-reader reliability of dynamic ultrasound images in power Doppler ultrasonography.

Koski JM, Saarakkala S, Helle M, Hakulinen U, Heikkinen JO, Hermunen H, Balint P, Bruyn GA, Filippucci E, Grassi W, Iagnocco A, Luosujärvi R, Manger B, De Miguel E, Naredo E, Scheel AK, Schmidt WA, Soini I, Szkudlarek M, Terslev L, Uson J, Vuoristo S, Ziswiler HR.

Ann Rheum Dis. 2006 Dec;65(12):1658-60. Epub 2006 May 25.

19.

[Inflamed joint: how to examine].

Luosujärvi R.

Duodecim. 2006;122(3):325-31. Review. Finnish. No abstract available.

PMID:
16619890
20.

Effectiveness of anakinra in rheumatic disease in patients naive to biological drugs or previously on TNF blocking drugs: an observational study.

Konttinen L, Kankaanpää E, Luosujärvi R, Blåfield H, Vuori K, Hakala M, Rantalaiho V, Savolainen E, Uutela T, Nordström D; ROB-FIN Study Group.

Clin Rheumatol. 2006 Nov;25(6):882-4. Epub 2006 Mar 22.

PMID:
16552464
21.

Cervical spine surgery in patients with rheumatoid arthritis: longterm mortality and its determinants.

Ronkainen A, Niskanen M, Auvinen A, Aalto J, Luosujärvi R.

J Rheumatol. 2006 Mar;33(3):517-22.

PMID:
16511921
22.

Stem cell transplantation in autoimmune diseases: an update.

Jantunen E, Luosujärvi R.

Ann Med. 2005;37(7):533-41. Review.

PMID:
16278166
23.

How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience.

Kaarela K, Hakala M, Hannonen P, Kautiainen H, Korpela M, Leirisalo-Repo M, Luosujärvi R, Luukkainen R, Möttönen T, Puolakka K.

Rheumatology (Oxford). 2005 Jan;44(1):134-5; author reply 135-6. No abstract available.

PMID:
15611310
24.

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.

Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, Peter HH, Breedveld FC, Fibbe WE, Black C, Denton C, Koetter I, Locatelli F, Martini A, Schattenberg AV, van den Hoogen F, van de Putte L, Lanza F, Arnold R, Bacon PA, Bingham S, Ciceri F, Didier B, Diez-Martin JL, Emery P, Feremans W, Hertenstein B, Hiepe F, Luosujärvi R, Leon Lara A, Marmont A, Martinez AM, Pascual Cascon H, Bocelli-Tyndall C, Gluckman E, Gratwohl A, Tyndall A; EBMT/EULAR Registry.

Ann Rheum Dis. 2004 Aug;63(8):974-81.

25.

Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey.

Savolainen E, Kaipiainen-Seppänen O, Kröger L, Luosujärvi R.

J Rheumatol. 2003 Nov;30(11):2460-8.

PMID:
14677193
26.

Joint symptoms and diseases associated with moisture damage in a health center.

Luosujärvi RA, Husman TM, Seuri M, Pietikäinen MA, Pollari P, Pelkonen J, Hujakka HT, Kaipiainen-Seppänen OA, Aho K.

Clin Rheumatol. 2003 Dec;22(6):381-5. Epub 2003 Oct 14.

PMID:
14677010

Supplemental Content

Loading ...
Support Center